SHARJAH: Al Qassimi Hospital, the largest referral hospital under Emirates Health Services, has performed 106 open-heart surgeries and 1,312 catheterisations in the first half of 2024, reinforcing its status as a leading centre for cardiac care in the region. The hospital is recognised for its advanced diagnostic and therapeutic solutions, achieving high success rates in line with global standards. According to Emirates News Agency, Dr. Arif Al Nooryani, Director of Al Qassimi Hospital, highlighted the hospital's accreditation by the Joint Commission International as the first global centre of excellence for treating atrioventricular blockages. It has also been designated as a referral centre for treating acute myocardial infarction. The hospital employs cutting-edge technologies like the "Dynamx" stent and advanced bioresorbable stents, such as "Fantom" and "Freesolve", marking regional firsts in their use. The hospital utilises advanced imaging equipment for precise diagnoses and stent placement, and has adopted the RRCOR system for treating hypertension. In arrhythmia treatment, it has introduced the "AVEIR DR" dual-chamber device and "PulseSelect" technology, making significant strides in the Middle East. Al Qassimi Hospital is committed to continuous medical education, collaborating with international experts and major medical companies to enhance local competencies. Its community initiatives include the "Just for You" campaign for early detection and awareness of heart diseases. Looking ahead, the hospital plans to expand with new catheterisation labs and an innovation centre, supporting the UAE's vision to be a global leader in medical excellence. These efforts underscore Emirates Health Services' dedication to advancing healthcare and strengthening the UAE's reputation in cardiovascular treatment.